NO951122L - Anvendelse av hyaluronsyre for å forhindre arteriell restenose - Google Patents

Anvendelse av hyaluronsyre for å forhindre arteriell restenose

Info

Publication number: NO951122L
Authority: NO; Norway
Prior art keywords: hyaluronic acid; arterial restenosis; prevent arterial; prevent; restenosis
Prior art date: 1992-09-25

Application number

NO951122A

Other languages

English (en)

Other versions

NO309457B1 (no

NO951122D0 (no

Inventor

Rudolf Edgar Falk

Samuel Simon Sculai

Eva Anne Turley

Original Assignee

Norpharmco Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1992-09-25

Filing date

1995-03-23

Publication date

1995-03-23

1993-09-22 Priority claimed from PCT/CA1993/000388 external-priority patent/WO1994007505A1/en

1995-03-23 Application filed by Norpharmco Inc filed Critical Norpharmco Inc

1995-03-23 Publication of NO951122L publication Critical patent/NO951122L/no

1995-03-23 Publication of NO951122D0 publication Critical patent/NO951122D0/no

2001-02-05 Publication of NO309457B1 publication Critical patent/NO309457B1/no

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers

Landscapes

Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Vascular Medicine (AREA)
Epidemiology (AREA)
Molecular Biology (AREA)
Urology & Nephrology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Materials For Medical Uses (AREA)
Polysaccharides And Polysaccharide Derivatives (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Saccharide Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicinal Preparation (AREA)

NO951122A 1992-09-25 1995-03-23 Anvendelse av hyaluronsyre i fremstillingen av en farmasöytisk sammensetning for å forhindre arteriell restenose NO309457B1 (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
CA002079205A CA2079205C (en)	1992-09-25	1992-09-25	Use of hyaluronic acid and forms to prevent arterial restenosis
PCT/CA1993/000388 WO1994007505A1 (en)	1991-07-03	1993-09-22	Use of hyaluronic acid and forms to prevent arterial restenosis

Publications (3)

Publication Number	Publication Date
NO951122L true NO951122L (no)	1995-03-23
NO951122D0 NO951122D0 (no)	1995-03-23
NO309457B1 NO309457B1 (no)	2001-02-05

Family

ID=4150463

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO951122A NO309457B1 (no)	1992-09-25	1995-03-23	Anvendelse av hyaluronsyre i fremstillingen av en farmasöytisk sammensetning for å forhindre arteriell restenose

Country Status (26)

Country	Link
EP (1)	EP0661981B1 (no)
JP (1)	JP3742955B2 (no)
CN (1)	CN1057908C (no)
AP (1)	AP448A (no)
AT (1)	ATE141054T1 (no)
AU (1)	AU670117B2 (no)
BR (1)	BR9307221A (no)
CA (1)	CA2079205C (no)
CZ (1)	CZ288986B6 (no)
DE (1)	DE69303931T2 (no)
DK (1)	DK0661981T3 (no)
ES (1)	ES2091031T3 (no)
GR (1)	GR3021171T3 (no)
HK (1)	HK35397A (no)
HU (2)	HU227067B1 (no)
IL (1)	IL107087A0 (no)
IN (1)	IN181289B (no)
MD (1)	MD960294A (no)
MX (1)	MX9305887A (no)
NO (1)	NO309457B1 (no)
NZ (1)	NZ255978A (no)
PL (1)	PL308201A1 (no)
SG (1)	SG48845A1 (no)
SK (1)	SK36895A3 (no)
TW (1)	TW271401B (no)
ZA (1)	ZA937068B (no)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5811447A (en)	1993-01-28	1998-09-22	Neorx Corporation	Therapeutic inhibitor of vascular smooth muscle cells
US6515009B1 (en)	1991-09-27	2003-02-04	Neorx Corporation	Therapeutic inhibitor of vascular smooth muscle cells
US6491938B2 (en)	1993-05-13	2002-12-10	Neorx Corporation	Therapeutic inhibitor of vascular smooth muscle cells
US6663881B2 (en)	1993-01-28	2003-12-16	Neorx Corporation	Therapeutic inhibitor of vascular smooth muscle cells
US5981568A (en)	1993-01-28	1999-11-09	Neorx Corporation	Therapeutic inhibitor of vascular smooth muscle cells
US6387413B1 (en) *	1997-08-22	2002-05-14	Denki Kagaku Kogyo Kabushiki Kaisha	Hyaluronic acid gel, a method of its production and medical material containing it
FR2813791B1 (fr)	2000-09-14	2004-03-12	Lafon Labor	Utilisation de 2- et 4-quinolones pour inhiber la neo-proliferation intimale
FR2994846B1 (fr)	2012-08-29	2014-12-26	Vivacy Lab	Composition, sterilisee, comprenant au moins un acide hyaluronique et de l'ascorbyl phosphate de magnesium

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA1340994C (en) *	1989-09-21	2000-05-16	Rudolf Edgar Dr. Falk	Treatment of conditions and disease

1992
- 1992-09-25 CA CA002079205A patent/CA2079205C/en not_active Expired - Lifetime
1993
- 1993-09-22 JP JP50854394A patent/JP3742955B2/ja not_active Expired - Lifetime
- 1993-09-22 DK DK93920624.9T patent/DK0661981T3/da active
- 1993-09-22 MD MD96-0294A patent/MD960294A/ro not_active Application Discontinuation
- 1993-09-22 NZ NZ255978A patent/NZ255978A/en not_active IP Right Cessation
- 1993-09-22 AU AU48126/93A patent/AU670117B2/en not_active Expired
- 1993-09-22 BR BR9307221A patent/BR9307221A/pt not_active Application Discontinuation
- 1993-09-22 PL PL93308201A patent/PL308201A1/xx unknown
- 1993-09-22 SK SK368-95A patent/SK36895A3/sk unknown
- 1993-09-22 TW TW082107796A patent/TW271401B/zh active
- 1993-09-22 DE DE69303931T patent/DE69303931T2/de not_active Expired - Lifetime
- 1993-09-22 CZ CZ1995662A patent/CZ288986B6/cs not_active IP Right Cessation
- 1993-09-22 AP APAP/P/1993/000568A patent/AP448A/en active
- 1993-09-22 SG SG1996002824A patent/SG48845A1/en unknown
- 1993-09-22 ES ES93920624T patent/ES2091031T3/es not_active Expired - Lifetime
- 1993-09-22 EP EP93920624A patent/EP0661981B1/en not_active Expired - Lifetime
- 1993-09-22 AT AT93920624T patent/ATE141054T1/de active
- 1993-09-22 HU HU9500857A patent/HU227067B1/hu unknown
- 1993-09-23 IL IL107087A patent/IL107087A0/xx not_active IP Right Cessation
- 1993-09-24 MX MX9305887A patent/MX9305887A/es unknown
- 1993-09-24 ZA ZA937068A patent/ZA937068B/xx unknown
- 1993-09-24 CN CN93119844A patent/CN1057908C/zh not_active Expired - Fee Related
1995
- 1995-03-23 NO NO951122A patent/NO309457B1/no not_active IP Right Cessation
- 1995-06-13 IN IN670CA1995 patent/IN181289B/en unknown
- 1995-06-30 HU HU95P/P00651P patent/HU211698A9/hu unknown
1996
- 1996-09-26 GR GR960402522T patent/GR3021171T3/el unknown
1997
- 1997-03-20 HK HK35397A patent/HK35397A/xx not_active IP Right Cessation

Also Published As

Publication number	Publication date
IL107087A0 (en)	1993-12-28
HU211698A9 (en)	1995-12-28
EP0661981A1 (en)	1995-07-12
SK36895A3 (en)	1997-03-05
AU670117B2 (en)	1996-07-04
DK0661981T3 (da)	1996-12-23
HK35397A (en)	1997-03-27
HUT73637A (en)	1996-08-28
PL308201A1 (en)	1995-07-24
NO309457B1 (no)	2001-02-05
EP0661981B1 (en)	1996-08-07
CA2079205C (en)	1998-02-10
IN181289B (no)	1998-05-02
AU4812693A (en)	1994-04-26
CN1057908C (zh)	2000-11-01
CN1092654A (zh)	1994-09-28
BR9307221A (pt)	1999-07-27
MX9305887A (es)	1994-05-31
DE69303931D1 (de)	1996-09-12
HU9500857D0 (en)	1995-05-29
SG48845A1 (en)	1998-05-18
AP9300568A0 (en)	1993-10-31
ATE141054T1 (de)	1996-08-15
CZ288986B6 (cs)	2001-10-17
NO951122D0 (no)	1995-03-23
CZ66295A3 (en)	1996-02-14
JPH08506797A (ja)	1996-07-23
DE69303931T2 (de)	1997-01-09
TW271401B (no)	1996-03-01
ZA937068B (en)	1994-04-18
MD960294A (ro)	1997-10-31
ES2091031T3 (es)	1996-10-16
CA2079205A1 (en)	1994-03-26
AP448A (en)	1996-01-18
GR3021171T3 (en)	1996-12-31
JP3742955B2 (ja)	2006-02-08
NZ255978A (en)	1997-02-24
HU227067B1 (en)	2010-06-28

Publication	Publication Date	Title
FI935768A (fi)	1993-12-21	I fysiologisk omgivning upploesande mineralfibrer
KR100315371B1 (ko)	2002-06-20	히알루론산을포함하는제형
FI954007A (fi)	1996-03-01	Substituoitujen 4-fenyyli-6-amino-nikotiinihappojohdannaisten käyttö lääkeaineena
NO995245L (no)	1999-12-27	Anvendelse av tetrahydropyridinderivater for fremstilling av medisiner for å behandle sykdommer som bevirker demyelinisering
NO980473D0 (no)	1998-02-03	Anvendelse av flukonazol for å inhibere cancervekst
AU6422294A (en)	1995-10-17	Use of hyaluronic acid and forms to prevent arterial restenosis
ZA931489B (en)	1993-10-28	Use of interleuken-10 to suppress graft-vs-host disease
NO951122L (no)	1995-03-23	Anvendelse av hyaluronsyre for å forhindre arteriell restenose
NO944933D0 (no)	1994-12-19	Fremgangsmåte for å inhibere sykdomstilstander i brystet
HU912010D0 (en)	1991-12-30	Utilization of macroring amino-phosphonic acid complexes as transformation agents
NO940190L (no)	1994-01-19	Anvendelse av alpha-ketoglutarat
FI954422A0 (fi)	1995-09-19	Ferroseenin käyttö
IT227994Y1 (it)	1998-02-05	Struttura di cinturino
NO923728D0 (no)	1992-09-25	Regioselektiv syntese av 1,5-diarylpyrazol-antiinflammatoriske midler
GB9525828D0 (en)	1996-02-21	Use of hetarylacetic acid derivatives
ITMI930749A0 (it)	1993-04-16	Derivato dell'acido iodesossicolico
EP0467840A3 (en)	1992-10-28	Derivatives of cyclopropyle acetic acid
KR970003624U (ko)	1997-01-24	처짐이 방지되는 모니터의 백커버
ZA926938B (en)	1994-03-11	Further novel 5-amino-4-hydroxyhexanoic acid derivatives as therapeutic agents
KR970035160U (ko)	1997-07-26	범퍼의 처짐방지를 위한 범퍼 결합구조
KR930020802U (ko)	1993-10-15	장신구의 연결구조
LV10948A (lv)	1995-12-20	Karbazolona atvasinajumi un to iegusanas panemiens
SE9203263D0 (sv)	1992-11-03	Vattenlaas av skruvtyp
FI567U1 (fi)	1993-03-08	Faestanordning foer faestande av en armbaogskrycka vid en arm
ITMI912186A1 (it)	1993-02-03	Derivato dell'acido 5-ammino salicilico

Legal Events

Date	Code	Title	Description
2013-10-07	MK1K	Patent expired